![]() Bruker Cellular Analysis Bruker Cellular Analysis (formerly known as Phenomex, Berkeley Lights) is a digital cell biology company focused on enabling the development of biotherapeutics and other cell-based products. | ![]() Sangamo Therapeutics Sangamo Therapeutics (formerly known as Sangamo BioSciences) is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of engineered DNA-binding proteins for the development of novel therapeutic strategies. | ![]() AbCellera Biologics AbCellera Biologics is a provider of an AI-powered drug discovery platform for antibody therapies. | ||
Founding Date | Founding Date 2011 | Founding Date 1995 | Founding Date 2013 | Founding Date 2012 |
Type | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | ||||
Locations | Locations Emeryville, US HQ | Locations Brisbane, US HQ Nice Area, FR Cheltenham, GB London, GB Richmond, US | Locations Philadelphia, US HQ | Locations Vancouver, CA HQ |
Employees | Employees 1391% decrease | Employees 35417% increase | Employees 36817% increase | Employees 596 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 416.4 m | Valuation ($) 4.4 b | Valuation ($) 833.9 m |
Financial | ||||
Revenue (est.) | Revenue (est.) $78.6m (FY, 2022) | Revenue (est.) $39.6m (FY, 2025) | Revenue (est.) $64.7m (FY, 2018) | Revenue (est.) $75.1m (FY, 2025) |
Net income | Net income ($98m) (FY, 2022) | Net income ($122.9m) (FY, 2025) | Net income ($78.8m) (FY, 2018) | Net income ($146.4m) (FY, 2025) |
Funding | ||||
Total funding raised | Total funding raised $ 124.7m | Total funding raised $ 74.2m | Total funding raised $ 122.8m | Total funding raised $ 115m |

Sangamo Therapeutics (formerly known as Sangamo BioSciences) is a clinical-stage biopharmaceutical company focused on the research, development, and commercialization of engineered DNA-binding proteins for the development of novel therapeutic strategies.
View company
Spark Therapeutics is a gene therapy company.
View company
AbCellera Biologics is a provider of an AI-powered drug discovery platform for antibody therapies.
View company